GPI-2A 20-mer oligonucleotide RNA antisense agent delivered by liposome: Phase I Update

Genesys Pharma Inc. (VSE:GPI), Winnipeg,

Read the full 52 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE